Cognitive effects of vanillic acid against streptozotocin-induced neurodegeneration in mice

Pharmaceutical Biology

Volumn 53, Issue 5, 2015, Pages 630-636

  Singh, Jayasingh Chellammal Hanish ^a   Kakalij, Rahul Motiram ^b   Kshirsagar, Rahul Padmakar ^b   Kumar, Boyina Hemanth ^b   Komakula, Sai Santosh Babu ^b   Diwan, Prakash Vamanrao ^b  

^a KPJ Healthcare University College   (Malaysia)

^b ANURAG UNIVERSITY   (India)

Author keywords

Acetylcholinesterase; Alzheimer's disease; Corticosterone; Oxidative stress; Tumor necrosis factor alpha

Indexed keywords

ACETYLCHOLINESTERASE; CATALASE; CORTICOSTERONE; GLUTATHIONE PEROXIDASE; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR ALPHA; VANILLIC ACID; ANTIOXIDANT; AUTACOID; NEUROPROTECTIVE AGENT; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTICLE; COGNITION; CONTROLLED STUDY; DRUG ACTIVITY; ENZYME ACTIVITY; HABITUATION; MALE; MAZE TEST; MOUSE; NERVE DEGENERATION; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; SPATIAL LEARNING; SPATIAL MEMORY; ANIMAL; ANTAGONISTS AND INHIBITORS; CHEMICALLY INDUCED; COGNITION DISORDERS; DRUG EFFECTS; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; METABOLISM; NEURODEGENERATIVE DISEASES;

ANGELICA SINENSIS; ANIMALIA; APIACEAE; MUS;

ANIMALS; ANTIOXIDANTS; COGNITION DISORDERS; INFLAMMATION MEDIATORS; INFUSIONS, INTRAVENTRICULAR; MALE; MICE; NEURODEGENERATIVE DISEASES; NEUROPROTECTIVE AGENTS; OXIDATIVE STRESS; STREPTOZOCIN; VANILLIC ACID;

EID: 84924422893     PISSN: 13880209     EISSN: 17445116     Source Type: Journal    
DOI: 10.3109/13880209.2014.935866     Document Type: Article

References (65)

1. Abidin I, Yargicoglu P, Agar A, et al. (2004). The effect of chronic restraint stress on spatial learning and memory: Relation to oxidant stress. Int J Neurosci 114:683-99.
2. Abraham IM, Harkany T, Horvath KM, Luiten PG. (2001). Action of glucocorticoids on survival of nerve cells: Promoting neurodegenera-tion or neuroprotection? J Neuroendocrinol 13:749-60
3. Agrawal R, Tyagi E, Shukla R, Nath C. (2009). A study of brain insulin receptors, AChE activity and oxidative stress in rat model of ICV STZ induced dementia. Neuropharmacology 56:779-87.
4. Alvarez A, Alarcon R, Opazo C, et al. (1998). Stable complexes involving acetylcholinesterase and amyloid-b peptide change the biochemical properties of the enzyme and increase the neurotoxicity of Alzheimer's fibrils. J Neurosci 18:3213-23.
5. Anderson DK, Saunders RD, Demediuk P, et al. (1985). Lipid hydrolysis and peroxidation in injured spinal cord: Partial protection with methylprednisolone or vitamin E and selenium. Cent Nerv Syst Trauma 2:257-67.
6. Behl C, Trapp T, Skutella T, Holsboer F. (1997). Protection against oxidative stress-induced neuronal cell death a novel role for RU486. Eur J Neurosci 9:912-20.
7. Blokland A, Jolles J. (1994). Behavioral and biochemical effects of an ICV injection of streptozotocin in old Lewis rats. Pharmacol Biochem Behav 47:833-7.
8. Boring L, Gosling J, Monteclaro FS, et al. (1996). Molecular cloning and functional expression of murine JE (monocyte chemoattractant protein 1) and murine macrophage inflammatory protein 1alpha receptors: Evidence for two closely linked C-C chemokine receptors on chromosome 9. J Biol Chem 271:7551-8.
9. Conrad CD, McLaughlin KJ, Harman JS, et al. (2007). Chronic glucocorticoids increase hippocampal vulnerability to neurotoxicity under conditions that produce CA3 dendritic retraction but fail to impair spatial recognition memory. J Neurosci 27:8278-85.
10. Coyle JT, Puttfarcken P. (1993). Oxidative stress, glutamate, and neurodegenerative disorders. Science 262:689-95.
11. Craft JM, Watterson DM, Van Eldik LJ. (2006). Human amyloid beta-induced neuroinflammation is an early event in neurodegeneration. Glia 53:484-90.
12. De A, Krueger JM, Simasko SM. (2005). Glutamate induces the expression and release of tumor necrosis factor-alpha in cultured hypothalamic cells. Brain Res 1053:54-61.
13. Dragsted LO. (2003). Antioxidant actions of polyphenols in humans. Int J Vitam Nutr Res 73:112-19.
14. Duelli R, Schrock H, Kuschinsky W, Hoyer S. (1994). Intracerebroventricular injection of streptozotocin induces discrete local changes in cerebral glucose utilization in rats. Int J Dev Neurosci 12:737-43.
15. Ellman GL, Courtney KD, Andres VJ, Feather-Stone RM. (1961). A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 7:88-95.
16. Floden AM, Li S, Combs CK. (2005). beta-Amyloid-stimulated micro-glia induce neuron death via synergistic stimulation of tumor necrosis factor alpha and NMDA receptors. J Neurosci 25:2566-75.
17. Goth L. (1991). A simple method for determination of serum catalase activity and revision of reference range. Clin Chim Acta 196:143-52.
18. Gould E, McEwen BS, Tanapat P, et al. (1997). Neurogenesis in the dentate gyrus of the adult tree shrew is regulated by psychosocial stress and NMDA receptor activation. J Neurosci 17:2492-8.
19. Haley TJ, McCormick WG. (1957). Pharmacological effects produced by intracerebral injection of drugs in the conscious mouse. Br J Pharmacol Chemother 12:12-15.
20. Hoyer S, Lannert H, Noldner M, Chatterjee SS. (1999). Damaged neuronal energy metabolism and behavior are improved by Ginkgo biloba extract (EGb 761). J Neural Transm 106:1171-88.
21. Hoyer S, Lannert H. (2008). Long-term effects of corticosterone on behavior, oxidative and energy metabolism of parietotemporal cerebral cortex and hippocampus of rats: Comparison to intracerebroven-tricular streptozotocin. J Neural Transm 115:1241-9.
22. Hoyer S. (1991). Abnormalities of glucose metabolism in Alzheimer's disease. Ann N Y Acad Sci 640:53-8.
23. Ishrat T, Hoda MN, Khan MB, et al. (2009). Amelioration of cognitive deficits and neurodegeneration by curcumin in rat model of sporadic dementia of Alzheimer's type (SDAT). Eur Neuropsychopharmacol 19:636-47.
24. Javed H, Khan MM, Khan A, et al. (2011). S-Allyl cysteine attenuates oxidative stress associated cognitive impairment and neurodegenera-tion in mouse model of streptozotocin-induced experimental dementia of Alzheimer's type. Brain Res 1389:133-42.
25. Koenigsknecht TJ, Landreth GE. (2005). Microglial phagocytosis induced by fibrillar beta-amyloid and IgGs are differentially regulated by proinflammatory cytokines. J Neurosci 25:8240-9.
26. Koladiya RU, Jaggi AS, Singh N, Sharma BK. (2008). Ameliorative role of atorvastatin and pitavastatin in L-methionine induced vascular dementia in rats. BMC Pharmacol 8:1-12.
27. Leal LK, Pierdona TM, Goes JG, et al. (2011). A comparative chemical and pharmacological study of standardized extracts and vanillic acid from wild and cultivated Amburana cearensis A.C. Smith. Phytomedicine 18:230-3.
28. Laursen SE, Belknap JK. (1986). Intracerebroventricular injections in mice. Some methodological refinements. J Pharmacol Methods 16: 355-7.
29. Lawrence RA, Burk RF. (1976). Glutathione peroxidase activity in selenium deficient rat liver. Biochem Biophys Res Commun 71:952-8.
30. Lester-Coll N, Rivera EJ, Soscia SJ, et al. (2006). Intracerebral streptozotocin model of type 3 diabetes: Relevance to sporadic Alzheimer's disease. J Alzheimers Dis 9:13-33.
31. Magarinos AM, McEwen BS. (1995). Stress-induced atrophy of apical dendrites of hippocampal CA3c neurons: Involvement of glucocortic-oid secretion and excitatory amino acid receptors. Neuroscience 69: 89-98.
32. Marklund S, Marklund G. (1974). Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur J Biochem 47:469-74.
33. Mattila P, Kumpulainen J. (2002). Determination of free and total phenolic acids in plant-derived foods by HPLC with diode-array detection. J Agric Food Chem 50:3660-7.
34. Mbebi C, Gonzalez de Aguilar JL, See V, et al. (2005). Antibody-bound beta-amyloid precursor protein stimulates the production of tumor necrosis factor-alpha and monocyte chemoattractant protein-1 by cortical neurons. Neurobiol Dis 19:129-41.
35. McEwen BS. (2000). Effects of adverse experiences for brain structure and function. Biol Psychiatry 48:721-31.
36. McEwen BS. (2001). Plasticity of the hippocampus: Adaptation to chronic stress and allostatic load. Ann N Y Acad Sci 933:265-77.
37. McIntosh LJ, Cortopassi KM, Sapolsky RM. (1998a). Glucocorticoids may alter antioxidant enzyme capacity in the brain: Kainic acid studies. Brain Res 791:215-22.
38. McIntosh LJ, Hong KE, Sapolsky RM. (1998b). Glucocorticoids may alter antioxidant enzyme capacity in the brain: Baseline studies. Brain Res 791:209-14.
39. McIntosh LJ, Sapolsky RM. (1996a). Glucocorticoids increase the accumulation of reactive oxygen species and enhance adriamycin-induced toxicity in neuronal culture. Exp Neurol 141:201-6.
40. McIntosh LJ, Sapolsky RM. (1996b). Glucocorticoids may enhance oxygen radical-mediated neurotoxicity. Neurotoxicology 17:873-82.
41. Metodiewa D, Koska C. (2000). Reactive oxygen species and reactive nitrogen species: Relevance to cyto(neuro)toxic events and neurologic disorders. An overview. Neurotox Res 1:197-233.
42. Olanow CW. (1993). A rationale for monoamine oxidase inhibition as neuroprotective therapy for Parkinson's disease. Mov Disord 8:S1-7.
43. Patel R, McIntosh L, McLaughlin J, et al. (2002). Disruptive effects of glucocorticoids on glutathione peroxidase biochemistry in hippocam-pal cultures. J Neurochem 82:118-25.
44. Pickering M, Cumiskey D, OConnor JJ. (2005). Actions of TNF- A on glutamatergic synaptic transmission in the central nervous system. Exp Physiol 90:663-70.
45. Plaschke K, Hoyer S. (1993). Action of the diabetogenic drug streptozotocin on glycolytic and glycogenolytic metabolism in adult rat brain cortex and hippocampus. Int J Dev Neurosci 11:477-83.
46. Racchi M, Mazzucchelli M, Porrello E, et al. (2004). Acetylcholinesterase inhibitors: Novel activities of old molecules. Pharmacol Res 50:441-51.
47. Ralay Ranaivo H, Craft JM, Hu W, et al. (2006). Glia as a therapeutic target: Selective suppression of human amyloid-beta-induced upregu-lation of brain proinflammatory cytokine production attenuates neurodegeneration. J Neurosci 26:662-70.
48. Ramirez MR, Izquierdo I, do Carmo Bassols Raseira M, et al. (2005). Effect of lyophilized Vaccinium berries on memory, anxiety and locomotion in adult rats. Pharmacol Res 52:457-62.
49. Reddy DS. (1997). Assessment of notropic and amnestic activity of centrally acting agents. Indian J Pharmacol 29:208-21.
50. Sato H, Takahashi T, Kazumi S, et al. (2010). Glucocorticoid generates ROS to induce oxidative injury in the hippocampus, leading to impairment of cognitive function of rats. J Clin Biochem Nutr 47: 224-32.
51. Saxena G, Singh SP, Pal R, et al. (2007). Gugulipid, an extract of Commiphora whighitii with lipid-lowering properties, has protective effects against streptozotocin-induced memory deficits in mice. Pharmacol Biochem Behav 86:797-805.
52. Saxena G, Singh SP, Agrawal R, Nath C. (2008). Effect of donepezil and tacrine on oxidative stress in intracerebral streptozotocin-induced model of dementia in mice. Eur J Pharmacol 581:283-9.
53. Scalbert A, Williamson G. (2000). Dietary intake and bioavailability of polyphenols. J Nutr 130:2073S-8S.
54. Schroeter H, Spencer JP, Rice-Evans C, Williams RJ. (2001). Flavonoids protect neurons from oxidized low-density-lipoprotein-induced apop-tosis involving c-Jun N-terminal kinase (JNK), c-Jun and caspase-3. Biochem J 358:547-57.
55. Sheikh N, Ahmad A, Siripurapu KB, et al. (2007). Effect of Bacopa monniera on stress induced changes in plasma corticosterone and brain monoamines in rats. J Ethnopharmacol 111:671-6.
56. Sies H. (1997). Oxidative stress: Oxidants and antioxidants. Exp Physiol 82:291-5.
57. Stellwagen D, Beattie EC, Seo JY, Malenka RC. (2005). Differential regulation of AMPA receptor and GABA receptor trafficking by tumor necrosis factor-alpha. J Neurosci 25:3219-28.
58. Storz G, Imlay JA. (1999). Oxidative stress. Curr Opin Microbiol 2: 188-94.
59. Taylor DL, Jones F, Kubota ES, Pocock JM. (2005). Stimulation of microglial metabotropic glutamate receptor mGlu2 triggers tumor necrosis factor alpha-induced neurotoxicity in concert with micro-glial-derived Fas ligand. J Neurosci 25:2952-64.
60. Tota S, Kamat PK, Awasthi H, et al. (2009). Candesartan improves memory decline in mice: Involvement of AT1 receptors in memory deficit induced by intracerebral streptozotocin. Behav Brain Res 199: 235-40.
61. Weinstock M, Kirschbaum-Slager N, Lazarovici P, et al. (2001). Neuroprotective effects of novel cholinesterase inhibitors derived from rasagiline as potential anti-Alzheimer drugs. Ann N Y Acad Sci 939:148-61.
62. Woodward CJ, Emery PJ. (1987). Determination of plasma cortico-sterone using high-performance liquid chromatography. J Chromatogr 419:280-4.
63. Yatin SM, Varadarajan S, Butterfield DA. (2000). Vitamin E prevents Alzheimer's amyloid beta-peptide (1-42) induced neuronal protein oxidation and reactive oxygen species production. J Alzheimers Dis 2: 123-31.
64. You JM, Yun SJ, Nam KN, et al. (2009). Mechanism of glucocorticoid-induced oxidative stress in rat hippocampal slice cultures. Can J Physiol Pharmacol 87:440-7.
65. Zou JY, Crews FT. (2005). TNF alpha potentiates glutamate neurotox-icity by inhibiting glutamate uptake in organotypic brain slice cultures: Neuroprotection by NF kappa B inhibition. Brain Res 1034:11-24.